SIC
TRIB

SJS Investment Consulting’s Trinity Biotech TRIB Stock Holding History

SJS Investment Consulting’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-67
Closed -$2.2K – 1701
2024
Q3 		$2.2K Buy
+67
New +$4.53K ﹤0.01% 746

Other funds holding TRIB

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

SJS Investment Consulting's TRIB Position: Q4 2024 in Review

SJS Investment Consulting sold out of Trinity Biotech (TRIB) in Q4 2024, closing a stake of 67 shares — an estimated $2.2K sold.

SJS Investment Consulting first reported a position in TRIB in Q3 2024 and held it in 1 quarter. The position peaked at $2.2K in Q3 2024. 21 funds tracked by Wall St. Rank hold TRIB as of Q4 2024.

  • SJS Investment Consulting reported no remaining Trinity Biotech position as of Q4 2024 after selling out during the quarter.
  • SJS Investment Consulting sold 67 Trinity Biotech shares in Q4 2024, an estimated $2.2K.
  • SJS Investment Consulting first reported a position in Trinity Biotech in Q3 2024 and held it in 1 quarter.
  • SJS Investment Consulting's Trinity Biotech position peaked at $2.2K in Q3 2024.
  • 21 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2024.

Based on SJS Investment Consulting's 13F filing for Q4 2024, filed 21 Jan 2025.